PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.45%
Revenue growth above 1.5x MRVL's 4.47%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
11.88%
Gross profit growth 1.25-1.5x MRVL's 8.73%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
20.05%
EBIT growth below 50% of MRVL's 109.98%. Michael Burry would suspect deeper competitive or cost structure issues.
20.81%
Operating income growth under 50% of MRVL's 109.98%. Michael Burry would be concerned about deeper cost or sales issues.
21.69%
Net income growth at 50-75% of MRVL's 41.54%. Martin Whitman would question fundamental disadvantages in expenses or demand.
22.86%
EPS growth at 50-75% of MRVL's 40.00%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
22.33%
Diluted EPS growth at 50-75% of MRVL's 40.00%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.60%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.69%
Reduced diluted shares while MRVL is at 1.51%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Dividend growth under 50% of MRVL's 0.11%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
87.79%
OCF growth at 75-90% of MRVL's 104.89%. Bill Ackman would demand better working capital management or cost discipline.
100.52%
FCF growth 50-75% of MRVL's 151.81%. Martin Whitman would see if structural disadvantages exist in generating free cash.
61.16%
10Y revenue/share CAGR 1.25-1.5x MRVL's 44.52%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
38.87%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
26.13%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
61.31%
10Y OCF/share CAGR above 1.5x MRVL's 6.19%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
63.85%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
33.59%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
137.49%
Below 50% of MRVL's 1280.26%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
87.46%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
66.91%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
41.50%
10Y equity/share CAGR in line with MRVL's 45.02%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
10.21%
Positive 5Y equity/share CAGR while MRVL is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
12.58%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
522.75%
Dividend/share CAGR of 522.75% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
191.83%
Dividend/share CAGR of 191.83% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.48%
3Y dividend/share CAGR above 1.5x MRVL's 0.12%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
7.28%
AR growth well above MRVL's 3.88%. Michael Burry fears inflated revenue or higher default risk in the near future.
-2.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.99%
Asset growth above 1.5x MRVL's 0.80%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.24%
BV/share growth above 1.5x MRVL's 0.54%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.07%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.